1. Insights into Dysregulated Neurological Biomarkers in Cancer
   Elisa Duranti et al, 2024, Cancers CrossRef
2. Biomarkers of mature neuronal differentiation and related diseases
   Xiaodong Yuan et al, 2024, Future Science OA CrossRef
3. Combined High—Throughput Proteomics and Random Forest Machine-Learning Approach Differentiates and Classifies Metabolic, Immune, Signaling and ECM Intra-Tumor Heterogeneity of Colorectal Cancer
   Cristina Contini et al, 2024, Cells CrossRef
4. Deciphering roles of protein post-translational modifications in IgA nephropathy progression and potential therapy
   Mengying Sun et al, 2024, Aging CrossRef
5. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma
   Qingge Jia et al, 2023, Pathology - Research and Practice CrossRef
6. Prognostic Significance of Elevated UCHL1, SNRNP200, and PAK4 Expression in High-Grade Clear Cell Renal Cell Carcinoma: Insights from LC-MS/MS Analysis and Immunohistochemical Validation
   Michał Kasperczak et al, 2024, Cancers CrossRef
7. Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson’s Disease
   Shayesteh Kokabi Hamidpour et al, 2024, Molecular Neurobiology CrossRef
8. Integrin α6β4 Upregulates PTPRZ1 Through UCHL1-Mediated Hif-1α Nuclear Accumulation to Promote Triple-Negative Breast Cancer Cell Invasive Properties
   Min Chen et al, 2024, Cancers CrossRef
9. Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson’s Disease
   Olga Buneeva et al, 2024, International Journal of Molecular Sciences CrossRef
10. Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy
    Jacopo Di Gregorio et al, 2024, Cells CrossRef